About Perrigo Laboratories India Private Limited
Data last updated:
Perrigo Laboratories India Private Limited was a private limited company based in Ambernath, Maharashtra, India, operated as a subsidiary of Professional, Scientific And Technical. The company has been converted to a Limited Liability Partnership (LLP) and no longer exists as a company. For the latest details, refer to the successor LLP. It operated in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 23 February 2005.
The company was registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2005PTC240217. Its GSTIN is 27AADCP5015A1ZZ (Maharashtra). The company held 3 GST registrations, of which 1 is active.
The company had an authorised share capital of ₹10 Lakh and a paid-up capital of ₹2.13 Lakh. It was led by directors Sumedha Nadkar Sanjeev (Whole-Time Director) and James Edwin Dillard Iii.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office was at Ambernath, Maharashtra.
As per the financials filed for FY 2022, the company reported a revenue of ₹33.99 Cr, a decline of 14% compared to the previous year. For the same year it recorded a net profit of ₹3.44 Cr (net margin 10.1%) and EBITDA of ₹7.26 Cr (EBITDA margin 21.3%). Revenue has declined at a compounded annual rate (CAGR) of 6% over three years and 4% over five years.
The company has about 25 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Perrigo. As per MCA filings, the company has satisfied charges of ₹50 Lakh on record.
The last known website on record is perrigo.com.
Company details
CIN history
Perrigo Laboratories India has one previous CIN (Corporate Identification Number): U24230AP2005PTC045453. The current CIN is U24230MH2005PTC240217, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24230MH2005PTC240217 | Current |
| U24230AP2005PTC045453 | Previous |
Contact details
Perrigo Laboratories India Private Limited's registered office is in Ambernath, Maharashtra. Its website is perrigo.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressBldg No. 8 Flat 004 Kailash Nagar Wadavli Section, India, Ambernath, Maharashtra, India – 421501
- IndustryPharma, Pharma Contract R&D
To see the full contact details of Perrigo Laboratories India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Perrigo Laboratories India operates one associated brand: Perrigo. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| APIs, OTC pharmaceuticals, and nutritional products are manufactured and distributed. | perrigo.com |
Business activity
The main business activity of Perrigo Laboratories India is professional, scientific and technical. In detail, this covers scientific research and development.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
To see the full business activity and turnover split of Perrigo Laboratories India Private Limited, buy the company report.
Financials of Perrigo Laboratories India Private Limited
FY 2022 filings availablePerrigo Laboratories India Private Limited reported revenue of ₹33.99 Cr (down 14% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 4% over five years, including a 14% fall in the latest year. EBITDA fell 17% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹7.26 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3.44 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 21.3% | ||||
| Net Profit Margin | 10.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Perrigo Laboratories India Private Limited, buy the company report.
Board of directors of Perrigo Laboratories India Private Limited
Perrigo Laboratories India has 2 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sumedha Nadkar Sanjeev | Whole-Time Director | 30 Sep 2015 | 11 Years 0 Months | As last reported |
| James Edwin Dillard Iii | Director | 21 Sep 2020 | 6 Years 1 Months | As last reported |
Peer comparison
Perrigo Laboratories India Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Contract Research), with the same principal business activity (scientific research and development), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Synergen Bio Private Limited | ₹36.01 Cr (FY 2024) | -25.0% | Pune, Maharashtra, India | |||
| Vergo Pharma Research Private Limited | ₹34.4 Cr (FY 2024) | -1.0% | Tiswadi, Goa, India | |||
| Perrigo Laboratories India Private Limitedthis company | ₹33.99 Cr (FY 2022) | ₹3.44 Cr | 10.1% | -14.0% | 25 | Ambernath, Maharashtra, India |
| Intonation Research Laboratories Private Limited | ₹33.31 Cr (FY 2025) | 14.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Perrigo Laboratories India Private Limited, buy the company report.
Auditor
Perrigo Laboratories India Private Limited is audited by S R Batliboi & Associates LLP for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S R Batliboi & Associates LLP | FY 2021 | 101049W/E300004 |
Shareholding
The shareholding of Perrigo Laboratories India Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Perrigo Laboratories India Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 21 Nov 2014 | 10544514 | The Hongkong and Shanghai Banking Corporation Limited | ₹50 Lakh | Satisfied |
To see the full charge records of Perrigo Laboratories India Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Perrigo Laboratories India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Perrigo Laboratories India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Perrigo Laboratories India Private Limited has a workforce of 25 employees on its EPFO records as of Apr 04, 2024, across 1 active EPFO establishment.
GST
Perrigo Laboratories India has 3 GST registrations: 1 active and 2 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AADCP5015A1ZZ | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Perrigo Laboratories India Private Limited, buy the company report.
Recent activity
Perrigo Laboratories India Private Limited has 10 board changes on record since 2015: 2 appointments and 8 cessations. The latest: Todd W Kingma ceased to be Director on 22 Dec 2020.
3 earlier events are in the company report.
News
Frequently asked questions
Perrigo Laboratories India has been "Converted to LLP" - the business changed its legal structure from a company to a Limited Liability Partnership. The original company no longer exists in its previous form. For the latest information, refer to the successor LLP entity registered with MCA.
Perrigo Laboratories India was a private limited company based in Ambernath, Maharashtra, India. The company worked in pharma contract r and d, within the pharma industry. It was incorporated on 23 February 2005 and is registered under CIN U24230MH2005PTC240217. For the latest details, refer to the successor LLP entity.
The CIN (Corporate Identification Number) of Perrigo Laboratories India is U24230MH2005PTC240217. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Perrigo Laboratories India had 2 directors:
- Sumedha Nadkar Sanjeev - Whole-Time Director
- James Edwin Dillard Iii - Director
Perrigo Laboratories India was incorporated on 23 February 2005. It is registered with the Registrar of Companies, Mumbai.
Perrigo Laboratories India can be reached through the website perrigo.com. Its registered office is in Ambernath, Maharashtra, India.
The registered office of Perrigo Laboratories India is at Bldg No. 8 Flat 004 Kailash Nagar Wadavli Section, India, Ambernath, Maharashtra, India – 421501.
The latest financial statements of Perrigo Laboratories India on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 30 September 2022. Year-wise statements from 2015 are in the company report.
The GSTIN of Perrigo Laboratories India is 27AADCP5015A1ZZ, registered in Maharashtra. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.
Perrigo Laboratories India operated in the pharma industry, in the pharma contract r and d segment.
The peers of Perrigo Laboratories India by revenue are Synergen Bio Private Limited, Vergo Pharma Research Private Limited, Intonation Research Laboratories Private Limited, all in the Pharma industry (Contract Research), with the same principal business activity (scientific research and development).